In This Section      
 

Ciccarone Articles

Ciccarone Center Research

Topic

Diabetes & Metabolic Syndrome

Landmark Articles

Insulin requirements in non-critically ill hospitalized diabetic patients with steroid-induced hyperglycemia.
By: Spanakis E, Shah N, Malhotra K, Yeh HC, Golden SH.

Noncritically ill patients with hyperglycemia receiving steroids require a higher percentage of TDD insulin therapy as nutritional insulin to achieve normoglycemia.

Read on Pubmed
Type 2 diabetes and cardiovascular disease: what next?
By: Joseph JJ, Golden SH.

CVD in Type 2 diabetes is multifactorial and requires a multifaceted approach in reducing known cardiovascular risks, at both the individual patient and societal levels.

Read on Pubmed
Insulin requirements in non-critically ill hospitalized patients with diabetes and steroid-induced hyperglycemia.
By: Spanakis EK, Shah N, Malhotra K, Kemmerer T, Yeh HC, Golden SH.

Noncritically ill patients with hyperglycemia receiving steroids require a higher percentage of total daily dose insulin therapy as nutritional insulin to achieve normoglycemia.

Read on Pubmed
Impact of a pharmacy-based glucose management program on glycemic control in an inpatient general medicine population.
By: Efird LE, Golden SH, Visram K, Shermock K.
This study found no global benefit of the pharmacy-based glucose management program for improving blood glucose values compared with usual care.
Read on Pubmed
Cardiac complications of obesity.
By: Ashen MD, Blumenthal RS.
Race/ethnic difference in diabetes and diabetic complications.
By: Spanakis EK, Golden SH.

This study's data provide novel updates on race/ethnic differences in children and adults with type 1 diabetes, children with type 2 diabetes, and in Latino subpopulations.

Read on Pubmed
Response to comment on: Draznin et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care.
By: Draznin B, Gilden J, Golden SH, Inzucchi S; PRIDE Investigators.
Read on Pubmed
High-priority research needs for insulin delivery and glucose monitoring methods.
By: Yeh HC, Lau BD, Golden SH, Donner T, Brown TT, Bass EB.
This article summarizes future research needs in the area of technologies for insulin delivery and glucose monitoring methods.
Read on Pubmed
A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
By: Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A, Erbel R, Blankstein R, Feldman T, Al-Mallah MH, Santos RD, Budoff MJ, Nasir K.

Considerable evidence supports the association of nonalcoholic fatty liver disease with subclinical atherosclerosis, independent of traditional risk factors and metabolic syndrome.

Read on Pubmed
Validity of meta-analysis in diabetes: meta-analysis is an indispensable tool in evidence synthesis.
By: Golden SH, Bass EB.
This article presents supporting arguments to support the use for meta-analysis in diabetes clinical research in a pro-con debate.
Read on Pubmed